Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease
Levothyroxine may improve major cardiovascular outcomes and decrease all-cause hospital admissions in patients with hypothyroidism and CVD.
Authors
- Jiajun Zhao (ORCID: https://orcid.org/0000-0003-3267-9292)
- Siyan Zhan (ORCID: https://orcid.org/0000-0003-1654-3678)
- Hou-Yu Zhao (ORCID: https://orcid.org/0000-0002-4546-9342)
- Shizhan Ma (ORCID: https://orcid.org/0000-0002-0506-6557)
- Zuoxiang Liu
- Xiaowei Chen (ORCID: https://orcid.org/0009-0009-2079-8105)
- Hongbo Lin (ORCID: https://orcid.org/0000-0002-9953-4752)
- Haiqing Zhang (ORCID: https://orcid.org/0000-0003-4396-4793)
- Meng Zhao (ORCID: https://orcid.org/0000-0002-8771-7834)
- Peng Shen (ORCID: https://orcid.org/0000-0002-3765-2630)
- Feng Sun (ORCID: https://orcid.org/0000-0002-8413-5177)
- Yexiang Sun (ORCID: https://orcid.org/0009-0006-2915-7521)
- Lijia Liu
Institutions
- Peking University (CN)
- Ministry of Education (RO)
- Ningbo Center for Disease Control and Prevention (CN)
- Shandong Provincial Hospital (CN)
- Peking University Third Hospital (CN)
- Shandong First Medical University (CN)
- Shandong Academy of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3389/fendo.2025.1640086
- Citations
- 2
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Merck KGaA
- National Natural Science Foundation of China